[Studies with the computer-guided perimeter "Peritest" on the effect of Cosaldon A+E on glaucomatous visual field defects].
Investigations on 114 glaucoma patients with the computerized perimeter 'Peritest' showed that treatment with Cosaldon A + E resulted in a decrease or elimination of visual field defects. Favourable results were also obtained with statistical significance for severe visual field defects of defect class greater than or equal to 2.0 log U. Treatment time was generally 4-5 months. During the first 6-10 weeks of treatment strong fluctuations were observed regarding individual sensitivity of light perception as well as number of defect positions.
D000328:Adult; D000368:Aged; D003201:Computers; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005901:Glaucoma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D013805:Theobromine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D058609:Visual Field Tests / Q000295:instrumentation / Q000379:methods*; D014794:Visual Fields / Q000187:drug effects*; D014801:Vitamin A / Q000494:pharmacology / Q000627:therapeutic use*; D014810:Vitamin E / Q000494:pharmacology / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; D014801:Vitamin A; D014810:Vitamin E; C025790:vitamin A, pentifyllin, nicotinic acid, and vitamin E combination; D013805:Theobromine
Untersuchungen mit dem computergesteuerten Perimeter Peritest über die Wirkung des Cosaldons A + E auf glaukomatöse Gesichtsfelddefekte.